Jeevan Scientific Technology Ltd Successfully Completes CDSCO Inspections

Jeevan Scientific Technology Ltd (JSTL) has completed inspections conducted by the Central Drugs Standard Control Organization (CDSCO) for its clinical and bioanalytical facilities. The successful completion of these inspections reinforces JSTL’s commitment to maintaining high regulatory standards and ensuring quality in pharmaceutical research.  

Key Highlights:  
- The CDSCO inspections covered JSTL’s clinical research site and bioanalytical research site, both located in Hyderabad.  
- The company specializes in bioavailability and bioequivalence studies, clinical trials, and pharmacovigilance services for pharmaceutical and biotech industries.  
- JSTL has previously undergone inspections by global regulatory bodies, including the USFDA, MHRA, and WHO, demonstrating its adherence to international standards.  
- The successful completion of the CDSCO inspections strengthens JSTL’s credibility in the clinical research domain, paving the way for further collaborations and approvals.  
- The company continues to expand its research capabilities, focusing on innovative solutions in drug development and regulatory compliance.  

JSTL’s achievement highlights its dedication to quality and compliance, ensuring that its research facilities meet the highest industry standards.  

Sources: Jeevan Scientific Technology Ltd, WHO Public Inspection Report, CDSCO Regulatory Updates